Hanna Hubarava

Author directory

2026

Controllable Automatic Text Simplification (CATS) produces user-tailored outputs, yet controllability is often treated as a decoding problem and evaluated with metrics that are not reflective to the measure of control. We observe that controllability in ATS is significantly constrained by data and evaluation. To this end, we introduce a domain-agnostic CATS framework based on instruction fine-tuning with discrete control tokens, steering open-source models to target readability levels and compression rates. Across three model families with different model sizes (Llama, Mistral, Qwen; 1-14B) and four domains (medicine, public administration, news, encyclopedic text), we find that smaller models (1-3B) can be competitive, but reliable controllability strongly depends on whether the training data encodes sufficient variation in the target attribute. Readability control (FKGL, ARI, Dale-Chall) is learned consistently, whereas compression control underperforms due to limited signal variability in the existing corpora. We further show that standard simplification and similarity metrics are insufficient for measuring control, motivating error-based measures for target-output alignment. Finally, our sampling and stratification experiments demonstrate that naive splits can introduce distributional mismatch that undermines both training and evaluation.
Every scientific text is embedded in the writing norms of its time: it reflects earlier publications while also shaping the texts that follow. The growing use of LLM-based writing tools introduces a new factor in this evolving system, but the linguistic changes coinciding with their emergence remain insufficiently understood. We investigate whether the trajectories of scientific-preprint writing changed in rate or direction after conversational LLMs became publicly accessible, using the release of ChatGPT in November 2022 as the observational breakpoint. We compare pre- and post-2022 trajectories across vocabulary, punctuation, readability, and syntax in abstracts from arXiv’s artificial intelligence, statistics, and quantitative biology categories and from medRxiv. Using interrupted time-series regression, we find substantial post-2022 changes across multiple feature families and research domains, including increases in average word length, reduced formula-based readability, and declines in maximum dependency-tree depth and sentence-level depth variation. Individual features follow different dynamics: some lexical markers accelerate persistently, while others rise and then recede. Our findings show that isolated marker frequencies capture only part of the shift: changes in the rate, direction, and structure of linguistic trajectories provide complementary evidence of broader post-2022 change in scientific-preprint writing. More broadly, these findings motivate monitoring scientific writing as a multidimensional, evolving system rather than through a fixed set of LLM-associated markers.

2025

Animal research, sometimes referred to as preclinical research, plays a vital role in bridging the gap between basic science and clinical applications. However, the rapid increase in publications and the complexity of reported findings make it increasingly difficult for researchers to extract and assess relevant information. While automation through natural language processing (NLP) holds great potential for addressing this challenge, progress is hindered by the absence of high-quality, comprehensive annotated resources specific to preclinical studies. To fill this gap, we introduce PreClinIE, a fully open manually annotated dataset. The corpus consists of abstracts and methods sections from 725 publications, annotated for study rigor indicators (e.g., random allocation) and other study characteristics (e.g., species). We describe the data collection and annotation process, outlining the challenges of working with preclinical literature. By providing this resource, we aim to accelerate the development of NLP tools that enhance literature mining in preclinical research.

2024